Today (2017 C.E. - 2025 C.E.)

This archive spans the years 2017 through 2025, a period marked by rapid advances in clean energy, medicine, technology, and social equity. It collects documented breakthroughs, policy wins, and scientific achievements from the present era. If you want evidence that progress is real and ongoing, this is where to look.

Horses on grassland, for article on Przewalski's horses

Wild horses return to Kazakhstan steppes after two-century absence

By / / Good News For Humankind

Przewalski’s horses—the only truly wild horse species left on Earth—are back on the Kazakh steppe after a two-century absence, with seven animals arriving from zoos in Berlin and Prague in June 2024. Their 30-hour flight aboard a Czech air force transport ended in the very landscape where humans likely first domesticated horses some 5,500 years ago. The herd is set to grow to 40 over the next five years, and the horses will quietly get to work as ecosystem engineers, spreading seeds and loosening soil as they roam. A similar effort in Mongolia has grown a wild population to roughly 1,500—a hopeful sign that this homecoming could ripple outward, restoring both a species and the grasslands that need it.

Bison, for article on Portugal wild bison

Portugal welcomes first wild bison in 10,000 years as part of plan to rewild a quarter-million acres

By / / Good News For Humankind

European wood bison are back in Portugal for the first time since the last Ice Age, with a small herd settling into the Greater Côa Valley. They came from Poland, where more than 4,000 wisent now roam wild — a remarkable turnaround for a species that survived the 20th century with just 50 animals left in zoos. Conservationists hope the bison will reshape the landscape through grazing and trampling, encouraging biodiversity and even helping break up the dense, dry vegetation that fuels Portugal’s wildfires. It’s a small herd with a big role to play, and a hopeful sign of what Europe’s growing rewilding movement can do when given room to breathe.

X-ray image of the intestine, for article on dostarlimab bowel cancer trial

New bowel cancer drug is found to be 100% effective

By / / Good News For Humankind

Immunotherapy just delivered something almost unheard of in cancer research: every single one of 42 patients in a rectal cancer trial showed no detectable tumour after treatment with the drug dostarlimab. Even more encouraging, the first 24 patients have now been tracked for an average of 26 months, and their cancers haven’t come back. For people with this specific subtype, it could mean skipping the chemotherapy, radiation, and surgery that often leave lasting damage. Larger studies are now underway to confirm the findings, but the signal is remarkable. It’s a glimpse of where cancer care may be heading worldwide — treatments that work with the body’s own immune system, and let patients keep their lives intact.

Contraceptives, for article on free contraception program

Free contraception initiative helps Finland reduce teenage abortions by 66%

By / / Good News For Humankind

Free contraception cut Finland’s teen abortion rate by 66% over roughly two decades, one of the steepest drops ever recorded in a high-income country. The shift came when municipalities began quietly weaving no-cost birth control into the same youth clinics where teenagers already get vaccines and check-ups, no awkward conversations or out-of-pocket costs required. Researchers say the lesson is refreshingly simple: young people aren’t avoiding contraception because they don’t understand it, but because of cost, stigma, or logistics — and Finland removed all three. As governments worldwide search for ways to support young people’s health and futures, this offers a quietly powerful blueprint: trust teenagers, meet them where they are, and the rest tends to follow.

Claudia Sheinbaum, for article on Mexico's first female president

Mexico elects Claudia Sheinbaum as first female president

By / / Good News For Humankind

Mexico’s first female president won her 2024 election by roughly 30 percentage points — not a squeaker, but a landslide. Claudia Sheinbaum, a climate scientist with a doctorate in energy engineering, takes office two centuries into the Mexican Republic’s history, in a country where women couldn’t even vote in national elections until 1953. One 87-year-old voter told Reuters she was simply grateful to be alive to see it. Sheinbaum has pledged to keep popular anti-poverty programs going and to address violence by investing in young people’s futures. In a world hungry for leaders who understand both science and social justice, her rise feels like a quiet shift in what’s possible — for Mexico, and far beyond it.

Holding breast cancer ribbon, for article on breast cancer recurrence blood test

New blood test can predict breast cancer return

By / / Good News For Humankind

A new blood test for breast cancer recurrence spotted returning disease an average of 15 months before symptoms or scans — and in one case, a full 41 months ahead of diagnosis. In a UK trial of 78 patients, the test correctly flagged every woman who later relapsed, scanning for 1,800 cancer-related mutations in tiny fragments of tumour DNA left circulating after treatment. Lead researcher Dr. Isaac Garcia-Murillas explained that dormant cells too few to show up on scans can trigger relapse years later — exactly the blind spot this test targets. If larger studies confirm the results, a simple blood draw could give oncologists precious extra time to act, reshaping how recurrence is caught worldwide.

School of fish, for article on Peru marine protected area

Peru approves the creation of long-awaited marine protected area

By / / Good News For Humankind

Peru’s new Grau Tropical Sea National Reserve safeguards 115,675 hectares of ocean where the warm Eastern Pacific meets the cold Humboldt Current — a collision the IUCN ranks among the 70 most vital places on Earth for marine biodiversity. Humpback whales birth their calves here, hammerhead sharks patrol the reefs, and scientists keep finding species entirely new to them. The reserve also matters for people: of the 35 main fish species landed by Peru’s artisanal fleet, 24 come from these waters. Created after more than a decade of advocacy by fishers and scientists, the designation is a real step toward the global goal of protecting 30% of the ocean by 2030 — and a reminder that lasting protection still depends on enforcement and political will.

A person preparing for planting the plant, for article on Colombian Amazon restoration

Campesinos plant nearly a million trees in deforestation hotspot in the Colombian Amazon

By / / Good News For Humankind

More than 700 campesino families in the Colombian Amazon have planted nearly a million native trees across former cattle pasture, transforming one of the country’s worst deforestation hotspots into recovering forest. In just four months, families across the Cuemaní region planted over 984,000 trees and palms — and tapirs, deer, and parrots that had disappeared with the chainsaws are already coming back. Teenagers who joined botanical surveys alongside scientists discovered they could earn a living as local forest experts, with some now pursuing degrees in agroforestry. What makes this remarkable isn’t just the scale, but the model: when the people who once cleared the land become its protectors, restoration starts to hold — a lesson echoing across the Amazon and beyond.

A researcher handling a vaccine vial in a clinical lab for an article about cancer vaccine trials, for article on cancer chemotherapy, for article on personalized cancer vaccine

NHS launches world-first cancer vaccine matchmaking program in England

By / / Good News For Humankind

Cancer vaccine trials are now being fast-tracked through a landmark NHS program in England that matches patients with personalized mRNA vaccines built around their individual tumors. The Cancer Vaccine Launch Pad, operating across 30 hospitals, uses the same mRNA technology behind COVID-19 vaccines to design custom treatments targeting each patient’s unique cancer mutations. The program aims to eliminate remaining cancer cells after surgery before they can return. Early immune response data is encouraging, and a 2024 trial showed a 44% reduction in melanoma recurrence when similar vaccines were combined with immunotherapy.

Karla Sofia Gascon, for article on Cannes Film Festival history

Karla Sofía Gascón becomes the first trans woman to win award for Best Actress at Cannes

By / / Good News For Humankind

Karla Sofía Gascón became the first openly transgender woman to win Best Actress at Cannes, sharing the 2024 honor with her three Emilia Pérez co-stars in a collective award chosen by Greta Gerwig’s jury. Gascón plays a Mexican drug lord who transitions in Jacques Audiard’s genre-bending musical, which also took home the festival’s Jury Prize. In her speech, she dedicated the win to “all trans people who suffer so much and must keep faith that changing is possible.” When a far-right politician responded with a transphobic post, six French LGBTQ+ groups filed a joint legal complaint — civil society closing ranks around her. Moments like this shift what young trans artists and audiences believe is possible.